In-Vitro Application of Magnetic Hybrid Niosomes: Targeted siRNA-Delivery for Enhanced Breast Cancer Therapy

Even though the administration of chemotherapeutic agents such as erlotinib is clinically established for the treatment of breast cancer, its efficiency and the therapy outcome can be greatly improved using RNA interference (RNAi) mechanisms for a combinational therapy. However, the cellular uptake...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Viktor Maurer, Selin Altin, Didem Ag Seleci, Ajmal Zarinwall, Bilal Temel, Peter M. Vogt, Sarah Strauß, Frank Stahl, Thomas Scheper, Vesna Bucan, Georg Garnweitner
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2021-03-01
Saila:	Pharmaceutics
Gaiak:	gene delivery siRNA magnetic targeting niosomes hybrid nanoparticles
Sarrera elektronikoa:	https://www.mdpi.com/1999-4923/13/3/394
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!